Department of Obstetrics and Gynecology, Universidade Estadual de Campinas, Campinas, SP, Brazil.
Rev Bras Ginecol Obstet. 2022 Mar;44(3):264-271. doi: 10.1055/s-0041-1739314. Epub 2022 Feb 15.
The present update is a reassessment of the 2018 'Guidelines for HPV-DNA Testing for Cervical Cancer Screening in Brazil' (Zeferino et al.)9, according to the changes observed in new international guidelines and knowledge updates. The most relevant and recent guidelines were assessed. Questions regarding the clinical practice were formulated, and the answers considered the perspective of the public and private sectors of the Brazilian health system. The review addressed risk-based strategies regarding age to start and stop screening, the use of cytology and colposcopy to support management decisions, treatment, follow-up strategies, and screening in specific groups, including vaccinated women. The update aims to improve the prevention of cervical cancer and to reduce overtreatment and the misuse of HPV testing.
本更新是对 2018 年“巴西宫颈癌筛查 HPV-DNA 检测指南”(Zeferino 等人)的重新评估,9 根据新的国际指南和知识更新所观察到的变化。评估了最相关和最新的指南。针对临床实践提出了问题,并考虑了巴西卫生系统公共和私营部门的观点来回答问题。该综述涉及基于风险的筛查起始和终止年龄策略、细胞学和阴道镜检查在支持管理决策、治疗、随访策略以及特定人群(包括接种疫苗的女性)筛查中的应用。本次更新旨在改善宫颈癌的预防,减少过度治疗和 HPV 检测的滥用。